The role of Epstein-barr virus in the pathogenesis of atopic diseases;Rola wirusa EBV w patogenezie chorób alergicznych

Alergia Astma Immunologia

Volumn 10, Issue 4, 2005, Pages 169-174

  Szmidt, Anna ^a   Stańczyk przyłuska, Anna ^a  

^a Kości Uniwersytetu Medycznego ^*  (Poland)

Author keywords

Atopic diseases; Children; Epstein barr virus; Lymphocytes b

Indexed keywords

EID: 77950939090     PISSN: 14273101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Gooding LR. Virus proteins that counteract host immune defences. Cell 1992; 71: 5-7.
2. Mims CA. Interactions of viruses with the immune system. Clin Exp Immunol 1986; 66: 1-16.
3. Smith GA. Virus strategies for evasion of the host response to infection, Trends Microbiol 1994; 2: 81-88. (Pubitemid 24072105)
4. Oldstone MBA. Molecular mimicry and autoimmine disease. Cell 1987; 50: 819-820.
5. Papadopoulos NG, Papi A, Meyer J i wsp. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy. 2001 Jul; 31:1060-1066.
6. Corne JM, Marshall C i wsp. Frequency, severity and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: alongitudinal cohort study. Lancet 2002; 359: 831-834.
7. Sigurs N, Bjarnason R, Sigurbergsson F i wsp. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95: 500-505.
8. Stein RT, Sherril D, Morgan WJ i wsp. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-545.
9. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl): S76-82.
10. Gern J, Lamanshe RF, Buse WW. Early life origins of asthma. J Clin Invest 1999; 104: 837-848.
11. Osur SL. Viral respiratory infections in association with asthma and sinusitis: a review. Ann Allergy Asthma Immunol, 2002 Dec; 89: 553-560.
12. Dahl ME, Dabbagh K, Liggitt D i wsp. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 337-343.
13. Williams JV, Harris PA, Tollefson SJ i wsp. Human metapneumowirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004; 350: 443-450. (Pubitemid 38133764)
14. Strachan DP. Hay fever, hygiene, and household size. BMJ1989; 299: 1259-1260.
15. Illi S, Von Mutins E, Lau S i wsp. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001; 322: 390-395.
16. Matricardi PM., Rosmini F. Riondino S i wsp. Exposure to foodborne and orofecal microbes versus airborne virases in relation to atopy and allergic asthma: epidemiological study. Br Med J 2000; 320: 412-417.
17. Levis SA, Britton JR. Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever.Clin Exp Allergy 1998; 28: 1493-1500.
18. Shaheen SO, Aaby P, Hall AJ i wsp. Measles and atopy in GuineaBissau.Lancet 1996; 347: 1792-1796.
19. Matricardi PM, Rosmini F, Ferrigno L i wsp. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus.Br Med J 1997; 314: 999-1003.
20. Epstein MA, Achong BA, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet.1964; 1: 702-703.
21. Pathmanathan R i wsp. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Eng J Med 1995; 333: 693-698.
22. Weiss LM, Movahed LA, Warlike RA i wsp. Detection of Epstein-Barr virus genomes in Reed-Stemberg cells of Hodgkin 's disease. N Engl J Med 1989; 320: 502-506.
23. Robinson J, Brown N, Andiman W i wsp. Diffuse polyclonal Bcell lymphoma during primary infection with Epstein-Barr virus. N Engl J Med 1980; 302: 1293-1297. (Pubitemid 10112422)
24. Purtilo DT, Cassel CK, Yang JPS i wsp. X-linked recessive progressive combined variable immunodeficiency (Dunkan's disease). Lancet 1975; 1: 935-940.
25. Tobi M, Morag A, Ravid Z i wsp. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982; 1: 61-64.
26. DuBois RE, Seeley JK, Bms I i wsp. Chronic mononucleosis syndrome. South Med J 1984; 77: 1376-1382.
27. Straus SE, Tosato G, Armstrong G i wsp. Persisting illness and fatigue in adults with evidence of Epstein-Barr infection. Ann Intern Med 1985; 102: 7-16.
28. Randolph TG, Hetting RA. The coincidence of allergic disease, unexplained fatigue, and lymphadenopathy: possible diagnostic confusion with infectious mononucleosis. Am J Med Sci 1945; 209: 306-314.
29. Strannegard IL, Strannegard O. Epstein-Barr virus antibodies in children with atopic disease. Int Arch Allergy Appl Immunol 1981;64:314-329. (Pubitemid 11153165)
30. Rystedt I, Strannegard IL, Strannegard O. Increased serum levels of antibodies to Epstein-Barr vims in adults with history of atopic dermatitis. Int Arch Allergy Allergy Appl Immunol 1984; 75: 179-183. (Pubitemid 14067656)
31. Calvani M, Alessandri C, Paolone G i wsp. Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease. Pediatr Allergy Immunol. 1997; 8: 91-96.
32. Olson GB, Kanaan MN, Kelley LM i wsp. Correlation between allergy and persistent Epstein-Barr vims infections in chronicactive Epstein-Barr virus-infected patients 1986; 78: 308-314.
33. Olson GB, Kanaan MN, Gersuk GM i wsp. Specific allergeninduced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infection. J Allergy Clin Immunol, 1986; 78: 315-320.
34. Bahna SL, Horwitz CA, Fiala M i wsp. IgE response in heterophil-positive infectious mononucleosis. J Allergy Clin Immunol. 1979;62:167-173.
35. Heiner DC, Horwitz CA, Sequential changes of the five immunoglobulin classes and other responses in infectious mononucleosis. Int Arch Allergy Appl. Immunol 1984; 74: 8-11.
36. Thomas MR, Steinberg P, Votaw ML, Bayne NK, IgE levels in Hodgkin's disease. Ann Allergy 1976; 37:416-419.
37. Pullen H, Wright N, Murdock J McC. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet.1967; 2:1176-1178.
38. Patel BM. Skin rash with infectious mononucleosis and ampicillin. Pediatrics.1967; 40: 910-911.
39. Kerns D, Shira JE, Go S i wsp. Ampicillin rash in children. Relationship to penicillin allergy and infectious mononucleosis. Am J Dis Child.1973; 125:187-190.
40. Renn CN, Straff W, Dorfmuller A i wsp. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol. 2002; 147:1166-1170. (Pubitemid 36963023)
41. LeClaire AC, Martin CA, Hoven AD. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis. Ann Pharmacother. 2004; 38: 996-998. (Pubitemid 38657742)
42. McCloskey GL, Massa MC. Cephalexin rash in infectious mononucleosis. Cutis 1997; 59: 251-254.
43. Straus SE, Dale JK, Wright R i wsp. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol, 1988; 81: 791-795.
44. Nordbring F, Johansson SGO, Espmark A. Raised serum levels of IgE in infectious mononucleosis. Scand J Infect Dis 1972; 4: 119-124.
45. Paul CC, Keller JR, Armpriester JM. Epstei-Barr transformed limfocytes produce interleukin-5. Blood 1990; 75:1400-1403.
46. Baumann MA, Paul. CC. Interleukin-5 is an autocrine growth factor for Epstein-Barr viras-transformed B lymphocytes. Blood 1992;79:1763-1767.
47. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 663-665.
48. Woodruff PG, Khashar R, Lazarus SC i wsp. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001; 108: 753-758. (Pubitemid 33096206)
49. Ohnishi E, Iwata T, Inouye S i wsp. Transformed. B cell lines from peripheral mononuclear cells of patients with atopic dennatitis. J Interferon Cytokine Res. 1997; 17: 597-602.
50. Liu YJ, Cairns J, Holder MJ i wsp. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991; 21: 1107-1114.
51. Vaux DL, Cory S Adams JM. Bel-gene promotes haemopoietic cellsurvival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-442.
52. Nakagomi H, Colcetti R, Bejarno MT i wsp. The Epstein-Barr virus latent membrane protein-1 (LMIP1) induces interleukin-10 production in Burkitt lymphoma lines. Int J Cancer 1994; 57: 240-244.
53. Nagafuchi S, Otsuka T, Niho Y. Chronic EB virus infection and cytokine:IL-2, interferon gamma, and BCRF1 gene product (viral IL-10). Intern Med. 1993; 32: 945-947.
54. Miyazaki I, Cheung RK, Dosch HM. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 1993; 178: 439-447. (Pubitemid 23218192)
55. Kanegane H, Wakiguchi H, Kanegane C i wsp. Viral interleukin10 in chronic active Epstein-Barr vims infection. J Invest Dis. 1997; 176: 254-257. (Pubitemid 27272878)
56. Irsch J, Humzelmann N, Tesch H i wsp. Isolation and characterisation of allergen-binding cells from normal and allergic donors. Immunotechnology 1995; 1: 115-125.
57. Martinez-Maza O. Guilbert B, David B, Avrameas S. The Epstein-Barr virus-induced production of IgE by human B cells. Clin Immunol Immunopathol 1986; 39: 405-413. (Pubitemid 16080788)
58. Van der Heijden FL, van Neerven RJ, Kapsenberg ML. Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients. Clin Exp Immunol 1995; 99: 289-293.
59. Shieh B, Schultz J, Guiness M i wsp. Regulation of the human IgE receptor (Fc epilon RII/CD23) by Epstein-Barr virus(EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23. Int Immunol 1997; 9: 1885-1895.
60. Hashimoto S, Takei M, Gon Y i wsp. Eleviation of soluble CD23 in sera from patients with infectious mononucleosis. J Med. Virol 1997; 53: 384-387. (Pubitemid 28228365)
61. Okudaira H, Ishizaka K, Reaginic antibody formation in the mouse. XI. Participation of long-lived, antibody-forming cells in persistent antibody formation. Cell Immunol 1981;58:188-201.
62. Okudaira H, Shuto H, Shuto T i wsp. A shadow of Epstein-Barr virus in the pathogenesis of atopic diseases. Clin Exp Allergy 2001; 31: 18-24.
63. Pereira MS, Blake JM, Macrae AD. EB virus anibody at different ages. Br Med J 1969; 4; 526-527.
64. Porter DD, Wimbrly I, Benyesh-Melnick M. Prevalence of antibodies to EBV virus and other herpesviruses. JAMA1969; 208: 1675-1679.
65. Godshall SF, Kirchner JT. Infectious mononucleosis. Postg Mied 2000; 107: 175-186
66. Sidorchuk A, Lagarde F, Pershagen G i wsp. Epstein-Barr virus infection is not associated with development of allergy inchildren. Pediatr Infect Dis J. 2003; 22: 642-647.
67. Auwaerter PG. Infectious mononucleosis in middle age. JAMA 1999;281:454-459.
68. Niederman JC, Miller G, Pearson HA i wsp. Infectious mononucleosis Epstein-Barr virus shedding in saliva and the oropharynx. N Engl J Med 1976; 294: 1355-1359.
69. Bellinghausen I, Knopp J, Saloga J. The role of interleukin 10 in the regulation of allergic immune responses. Int Arch Allergy Immunol 2001; 126:97-101. (Pubitemid 33135386)
70. Borish L, Rosenwasser IJ. Update on cytokines. J Allergy Clin Immunol 1996; 97: 719-733.
71. Royer B, Varadaradjalon S, Saas P i wsp. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy 2001; 31:694-704.
72. Hodge S, Hodge G, Flower R i wsp. Methyl-prednisolone upregulates monocyte interleukin 10 production in stimulated whole blood. Scand J Immunol. 1999; 49: 548-553. (Pubitemid 29243128)
73. Akdis CA, Joss A, Akdis M, Blaser K. Mechanisms of IL-10) induced T cell inactivation in allergic inflammation and normal response to allergens. Int Arch Allergy Immunol 2001; 124:180-182. (Pubitemid 32304797)
74. Akdis CA, Blesken T, Akdis M i wsp. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106. (Pubitemid 28323835)
75. Akdis CA, Blesken T, Wymann D i wsp. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur J Immunol 1998; 28: 914-925. (Pubitemid 28116205)